Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here come the shorts ... obvious when they show up.
If it weren’t for Greg shenanigans this would be stable at 30cents.
Hey Steve how about a shareholders meeting? Wtf? Act like a pubco
VYST has the potential of a $1 stock. Big daddy Steve needs to make some deals. Let Greg stick to cheerleading.
Can the company show proof of $12mil per week and a target of 64cents PPS?
Even IF they don’t get recognition for Covid indications (which would be tragic), leronlimab is getting significant exposure with medical community for HIV and Cancer indications right now.
Whether AF and cohorts understand this or not ... they are helping CytoDyn awareness and the medicine speaks for itself.
Shameful practice in a time of pandemic. A good lawyer could argue it amounts to crimes against humanity. Which is why Congress proposed an SEC investigation into their stock price manipulation practices.
Thanks for the link.
It’s a paid subscription, I won’t pay for trash. If it was free, I’d read it. I watch fake news CNN for giggles as well.
NP reputation is what’s giving the short positions ammunition right now. Can’t erase history.
Bruce Patterson is the one who is directly responsible for the proper development of leronlimab.
Main reason this hasn’t been accepted by the public is that NP is Ceo. IMO. I’d like to hear from the BOD member they just hired, if he quits then you know NP is being difficult. Looking at history it looks like he wouldn’t be the first.
The science is deafening, leronlimab works Andy they know it. The issue is the threat to Gilead and NP unwillingness to play ball.
With a $1billion OS and $12mil/week revenue they stand to make $640 million per year on RXAir.
That’s a 64cent per share bare minimum with a P/E of 1:1.
All they have to do is prove production capability and sales. Seems simple these days but it also appears VYST can’t tie a shoe.
Who knows... but Steve can be held accountable for that account. The fact that it died while Greg was in “surgery” tells me they don’t know it exists or they simply use it when they want to sell shares.
Could be wrong, they could legitimately be ready for production as well... but who knows as they tend to suck at transparency.
Considering Greg’s past... it’s hard to believe anything. I still wonder if Steve knows that Twitter account exists.
Which is why people like AF suppress the PPS through misinformation. They know it’s the lifeblood to the company success.
Right now the misinformation is literally killing people worldwide by preventing leronlimab commercialization. It’s a crime against humanity.
The demand is there because there is no cure for Covid. Every building will be looking to cleanse their air. RXAir3000 is one of the few commercial units in that space, FDA certified class 2 medical device.
This is a gold mine right now if they can pull it off and not look like complete morons.
So per PR VYST is expecting $12mil per week in revenue for 1500 units per week @ $8k each.
That’s very possible but we’ll need to see more info since Greg’s history has been suspect. If Steve Rottman is driving this then I’ll have more confidence.
Bigger question is what idiot shareholder will jump in? They have much more to gain in the near future.
If anything I’ll thank them for any low prices we get short term. I’m trying to free up funds today to buy more CYDY. But... maybe they are too? The cost of a lawsuit (especially if frivolous) is nothing compared to the potential gains ahead.
NP better watch his words though. English isn’t his first language, sounds like he better get an FDA lawyer to review PRs.
Yeah, but it’s plastered on my Atrade newsfeed at the top of CYDY PRs. Can’t miss it.
I would agree... that was a poorly written PR if they know the process was not “complete” but submitted. Words matter.
Frivolous lawsuit that will depend on a dictionary interpretation of completed.
That’s why they improved the systems and reestablished the supply chain.
Lol, loss? The loss would be due to AF and stock manipulation not FDA asking for more data.
Nope, it would be through the roof by now. I think Nasdaq lists all otcbb stocks as Nasdaq
Ok. False alarm then. Maybe E*TRADE lists all OTCBB stocks as Nasdaq. My Ameritrade still shows OTC.
My E*TRADE account shows they are on the Nasdaq now.
Still a rubber pipe dream... I’m hoping they’re focusing on the RXAir due to Covid panic. Salesman’s dream... mandatory demand.
Didn’t say in the PR. Has to be globally.... but there are a lot of buildings looking to reopen with some confidence they are breathing safe air. This has now grown from just hospital use to every building use. The demand is exponential now. If the Rotmans are smart they’ll make millions off of this... if it’s another BS PR well... shame on them they could have bought retirement for every Rottman employee with this crisis. We’ll see.
Wolf, You believe they are actually ready with the new improvements to the RXAir? $12mil a week?
If they are it’s perfect timing to sell into the Covid pandemic.
Would be nice to see some kind of proof.
Improvements to RxAir are finished. Production moved to MA and previous complaints about RXAIr addressed. According to PR they raised price on new improved units from $5000 to $8000 to sell into the Covid pandemic. 1500 a week, that’s $12mil revenue a week assuming they sell that much a week. With the Covid pandemic there could be that much demand. Steve Rottman put out a new PO.
Testing to prove its effective AFTER the improvements are finished.
Only the nature of the warrant paid to the company.
Don’t know officially, waiting on fins.
Good lord don’t use stat news as DD. They are biased as they have huge short positions underwater.
See the warrants.. and then wait for the paperwork for manufacturing.
This is just the beginning.
Share structure is a little heavier to lift but yes I agree... no reason why this can’t at least get to .10 if not .20 on RxAir commercial.
Retail won’t do much but that’s Greg’s problem after spin-off.
Because smart investors don’t ride the entire investment “to the moon” lol.
Take your profit and leave house money.
Funding the company through warrants just as the ceo asked.
What this tells me is that Greg gets the retail smaller versions of the RxAir and Big Daddy Rottman gets the commercial versions.
I.e. the spinoff will hopefully get Greg on his own and leave the big chunk of cash to daddy (VYST).
Let’s see the plan they keep taking about. I doubt there is one.
He’s a danger to everything Steve is working towards. How do we as shareholders shut down that twitter feed? He’s such a liability!
They need to get Greg off of Twitter!!!
PR was well written and there’s a disclaimer that says it’s not been tested against Covid.
So No it won’t be suspended.